Wolfgang N. Löscher

ORCID: 0000-0002-7593-3222
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peripheral Nerve Disorders
  • Peripheral Neuropathies and Disorders
  • Neurogenetic and Muscular Disorders Research
  • Hereditary Neurological Disorders
  • Myasthenia Gravis and Thymoma
  • Genetic Neurodegenerative Diseases
  • Nerve Injury and Rehabilitation
  • Neurological disorders and treatments
  • Orthopedic Surgery and Rehabilitation
  • Muscle activation and electromyography studies
  • Amyotrophic Lateral Sclerosis Research
  • Muscle Physiology and Disorders
  • Glycogen Storage Diseases and Myoclonus
  • Parkinson's Disease Mechanisms and Treatments
  • Musculoskeletal pain and rehabilitation
  • Spine and Intervertebral Disc Pathology
  • Botulinum Toxin and Related Neurological Disorders
  • Pain Mechanisms and Treatments
  • Neurological diseases and metabolism
  • Autoimmune Neurological Disorders and Treatments
  • Lysosomal Storage Disorders Research
  • Cardiomyopathy and Myosin Studies
  • Neuroscience and Neural Engineering
  • Motor Control and Adaptation
  • Inflammatory Myopathies and Dermatomyositis

Innsbruck Medical University
2016-2025

Universität Innsbruck
2015-2025

University Hospital Innsbruck
2002-2024

Essen University Hospital
2024

Ludwig-Maximilians-Universität München
2020-2024

Friedrich Baur Stiftung
2024

SMART Reading
2024

Medical University of Vienna
1999-2020

Polish Academy of Sciences
2020

Dr. John T. Macdonald Foundation
2020

James F. Howard Kimiaki Utsugisawa Michael Benatar Hiroyuki Murai Richard J. Barohn and 95 more Isabel Illa Saiju Jacob John Vissing Ted M. Burns John T. Kissel Srikanth Muppidi Richard J. Nowak Fanny O’Brien Jingjing Wang Renato Mantegazza Claudio Mazia Miguel Wilken Carolina Ortea Juliet Saba Marcelo Rugiero Mariela Bettini Gonzalo Vidal Alejandra Dalila Garcia Phillipa J. Lamont Wai Yie Leong Heidi Boterhoven Beverly Fyfe L. Jackson Roberts Mahi Jasinarachchi Natasha Willlems Julia Wanschitz Wolfgang N. Löscher Jan De Bleecker Guy Van den Abeele Kathy de Koning Katrien De Mey Rudy Mercelis Linda Wagemaekers Délphine Mahieu Philip Van Damme Charlotte Smetcoren Olivier Stevens Sarah Verjans Ann D’Hondt Petra Tilkin Alzira Alves de Siqueira Carvalho Rosa Hasan Igor Dias Brockhausen David Feder Daniel Ambrosio Ana Paula Souto Melo Rosana Rocha Bruno Bezerra Rosa Thabata Veiga Luiz Augusto da Silva Jordana Gonçalves Geraldo Maria da Penha Morita Ananias Érica Coelho Gabriel Pina Paiva M Tovar Pozo Natalia Prando Debora Dada Martineli Torres Cristiani Fernanda Butinhao Érica Coelho Luciana Renata Cubas Volpe Gustavo Duran Tamires Cristina Gomes da Silva Luiz Otavio Maia Gonçalves Lucas Eduardo Pazetto Luciana Souza Duca Tomás Augusto Suriane Fialho Maurício Friedrich Alexandre Guerreiro Henrique Mohr Maurer Pereira Martins Daiane da Cruz Pacheco Ana Paula Macagnan Aline de Cassia Santos Acary Souza Bullé Oliveira Ana Carolina Amaral de Andrade Marcelo Annes Valéria Cavalcante Lino Wladimir Bocca Vieira de Rezende Pinto Carolina Miranda Fernanda Carrara Iandra Souza Angela Genge Rami Massie Natasha Campbell Vera Bril Hans Katzberg Mehran Soltani Eduardo Ng Zaeem A. Siddiqi Celile Phan Derrick Blackmore Stanislav Voháňka Josef Bednařík Magda Chmelikova Marek Čierny

10.1016/s1474-4422(17)30369-1 article EN The Lancet Neurology 2017-10-23

To improve accuracy in the diagnosis of carpal tunnel syndrome (CTS) by comparing cross-sectional area (CSA) measurements median nerve obtained at level (CSAc) with those more proximally (CSAp), pronator quadratus muscle.The study protocol was approved institutional review board, and all subjects gave written informed consent. One hundred wrists 68 consecutive patients CTS (16 men, 52 women; mean age, 57.9 years; range, 25-85 years) 93 58 healthy volunteers male, 42 female; 55.1 17-85 were...

10.1148/radiol.2501080397 article EN Radiology 2008-11-27

<h3>Importance</h3> Intravenous edaravone is approved as a disease-modifying drug for patients with amyotrophic lateral sclerosis (ALS), but evidence efficacy limited to short-term beneficial effects shown in the MCI186-ALS19 study subpopulation which was expected. <h3>Objective</h3> To evaluate long-term safety and effectiveness of intravenous therapy ALS real-world clinical setting. <h3>Design, Setting, Participants</h3> Multicenter, propensity score–matched cohort conducted between June...

10.1001/jamaneurol.2021.4893 article EN JAMA Neurology 2022-01-10

Neurological sequelae from coronavirus disease 2019 (COVID-19) may persist after recovery acute infection. Here, the aim was to describe natural history of neurological manifestations over 1 year COVID-19.A prospective, multicentre, longitudinal cohort study in COVID-19 survivors performed. At a 3-month and 1-year follow-up, patients were assessed for impairments by examination standardized test battery including assessment hyposmia (16-item Sniffin' Sticks test), cognitive deficits...

10.1111/ene.15307 article EN cc-by European Journal of Neurology 2022-03-03

Evidence for the efficacy of nusinersen in adults with 5q-associated spinal muscular atrophy (SMA) has been demonstrated up to a period 16 months relatively large cohorts but whereas patients reach plateau over time is still be demonstrated. We investigated and safety SMA 38 months, longest date cohort from multiple clinical sites. Our prospective, observational study included adult Germany, Switzerland, Austria (July 2017 May 2022). All participants had genetically-confirmed, were treated...

10.1016/j.lanepe.2024.100862 article EN cc-by The Lancet Regional Health - Europe 2024-02-06
Ana Töpf Katherine Johnson Adam Bates Lauren Phillips Katherine R. Chao and 94 more Eleina England Kristen M. Laricchia T. Mullen Elise Valkanas Liwen Xu Marta Bértoli A. Blain Ana Casasús Jennifer Duff Magdalena Mroczek Sabine Specht Monkol Lek Monica Ensini Daniel G. MacArthur Ela Akay Jorge Alonso‐Pérez Jonathan Baets Nina Barišić Alexandra Bastian S. Borell Teodora Chamova Kristl G. Claeys Jaume Colomer Sandra Coppens Nicolas Deconinck Willem De Ridder Jordi Díaz‐Manera Cristina Domínguez‐González Alexis E. Duncan Hacer Durmuş Nagia Fahmy Maria Elena Farrugia Roberto Fernández‐Torrón Lídia González-Quereda Jana Haberlová Maja von der Hagen Andreas Hahn Antonia Jakovčević I. Jericó Pascual Solange Kapetanovic Viktorija Ķēniņa Janbernd Kirschner Andrea Klein Heike Kölbel Anna Kostera‐Pruszczyk R. Kulshrestha Jaana Lähdetie Mahsa Layegh Cheryl Longman Adolfo López de Munaín Wolfgang N. Löscher Anna Łusakowska Paul Maddison Armelle Magot Anirban Majumdar Pilar Martí Amaia Martínez Arroyo Radim Mazanec Sandra Mercier Tiziana Mongini Nuria Muelas A. Nascimento Shahriar Nafissi Shirin Jamal Omidi C. Ortez Stéphanie Paquay Yann Péréon Stojan Perić Valentina Ponzalino Vidosava Rakočević Stojanović Gauthier Remiche Aida Rodríguez Sainz Sabine Rudnik I Sánchez Albisua Manuela Santos Ulrike Schara Andriy Shatillo Jadranka Sertić Ulrich Stephani Sonja Strang‐Karlsson Yves Sznajer Ani Tanev Ivailo Tournev Peter Van den Bergh Vinciane Van Parijs Juan J. Vílchez Katharina Vill John Vissing Carina Wallgren‐Pettersson Julia Wanschitz Tracey Willis Nanna Witting Miren Zulaica Volker Straub

Several hundred genetic muscle diseases have been described, all of which are rare. Their clinical and heterogeneity means that a diagnosis is challenging. We established an international consortium, MYO-SEQ, to aid the work-ups disease patients better understand etiology.Exome sequencing was applied 1001 undiagnosed recruited from more than 40 neuromuscular referral centers; standardized phenotypic information collected for each patient. Exomes were examined variants in 429 genes associated...

10.1038/s41436-020-0840-3 article EN cc-by-nc-nd Genetics in Medicine 2020-06-11

10.1016/s1474-4422(21)00331-8 article EN The Lancet Neurology 2021-11-17

Abstract Previous studies have described the clinical, serological and pathological features of patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) antibodies directed against paranodal proteins neurofascin-155, contactin-1 (CNTN1), contactin-associated protein-1 (Caspr1), or nodal forms neurofascin. Such are useful for diagnosis potentially treatment selection. However, targeting Caspr1 only Caspr1/CNTN1 complex been reported in few CIDP. Moreover, it is unclear...

10.1093/brain/awab014 article EN Brain 2021-01-21

Cardiac troponin (cTn) T and cTnI are considered cardiac specific equivalent in the diagnosis of acute myocardial infarction. Previous studies suggested rare skeletal myopathies as a noncardiac source cTnT. We aimed to confirm reliability/cardiac specificity cTnT patients with various muscle disorders (SMDs).We prospectively enrolled presenting muscular complaints (≥2 weeks) for elective evaluation 4 hospitals 2 countries. After workup, were adjudicated into 3 predefined disease categories....

10.1161/circulationaha.121.058489 article EN Circulation 2022-04-07
Astrid Pechmann Max Behrens Katharina Dörnbrack Adrian Tassoni Sabine Stein and 95 more Sibylle Emilie Vogt Daniela Zöller G. Bernert Tim Hagenacker Ulrike Schara‐Schmidt Inge Schwersenz Maggie C. Walter Matthias Baumann Manuela Baumgärtner Marcus Deschauer Astrid Eisenkölbl Marina Flotats‐Bastardas Andreas Hahn Veronka Horber Ralf A. Husain Sabine Illsinger Jessika Johannsen Cornelia Köhler Heike Kölbel Monika Müller Arpad von Moers Kurt Schlachter Gudrun Schreiber Oliver Schwartz Martin Smitka Elisabeth Steiner Eva Stögmann Regina Trollmann Katharina Vill Claudia Weiß Gert Wiegand Andreas Ziegler Hanns Lochmüller Janbernd Kirschner Thea Beatrice Abele Bárbara Andres Daniela Angelova-Toshkina Petra Baum Tobias Baum Ute Baur Benedikt Becker Bettina Behring Theresa Birsak Julia Bellut Astrid Bertsche Markus Blankenburg Astrid Blaschek Nathalie Braun Sarah Braun Nadine Burgenmeister Nicole Claus Isabell Cordts Heike de Vries Timo Deba Adela Della Marina Jonas Denecke Joenna Driemeyer Matthias Eckenweiler Barbara Fiedler Michal Fischer Maren Freigang Johannes Friese Philippa Gaiser Axel Gebert Stephanie Geitmann Klaus Goldhahn Michael Grässl Kristina Gröning Julian Großkreutz U Gruber‐Sedlmayr Helene Guillemot René Günther Maja von der Hagen H. Hartmann Miriam Hiebeler Elke Hobbiebrunken Georg F. Hoffmann Britta Holtkamp Dorothea Holzwarth Eva Jansen Angela M. Kaindl Nadja Kaiser Jennifer Klamroth Jan Christoph Koch Stefan Koelker Kirsten Kolzter Brigitte Korschinsky Hanna Küpper Thorsten Langer Ilka Lehnert Paul Lingor Wolfgang N. Löscher Dana Loudovici-Krug Κyriakos Martakis Iris Mayer

Abstract 5q-associated spinal muscular atrophy is a rare neuromuscular disorder with the leading symptom of proximal muscle weakness. Three different drugs have been approved by European Medicines Agency and Food Drug Administration for treatment patients, however, long-term experience still scarce. In contrast to clinical trial data restricted patient populations short observation periods, we report here real-world evidence on broad spectrum patients early-onset treated nusinersen focusing...

10.1093/brain/awac252 article EN Brain 2022-07-20

Abstract In digenic inheritance, pathogenic variants in two genes must be inherited together to cause disease. Only very few examples of inheritance have been described the neuromuscular disease field. Here we show that predicted deleterious SRPK3 , encoding X-linked serine/argenine protein kinase 3, lead a progressive early onset skeletal muscle myopathy only when combination with heterozygous TTN gene. The co-occurrence / was not seen among 76,702 healthy male individuals, and statistical...

10.1038/s41588-023-01651-0 article EN cc-by Nature Genetics 2024-03-01

Abstract To determine magnetic resonance imaging (MRI) patterns of brain atrophy in parkinsonian syndromes, we applied voxel‐based morphometry (VBM) to segmented gray matter, white and cerebrospinal fluid compartments T 1 ‐weighted volumes 12 patients with probable multiple system atrophy–parkinson variant (MSA‐P) Parkinson's disease patients, comparing them normal controls matched for age. In comparison controls, a cortical pattern was observed MSA‐P significant clusters volume loss primary...

10.1002/mds.10502 article EN Movement Disorders 2003-10-01

1. This study was undertaken to examine changes of excitatory drive the triceps surae alpha‐motoneuron pool during fatiguing submaximal isometric contractions in man. Eight healthy subjects maintained plantar flexions at 30 percent maximum voluntary contraction (MVC) until limit endurance (range, 6‐9 min). 2. Excitability Ia afferent stimulation (H reflex), electromyograms (EMG) and compound motor unit action potentials (Mmax) from lateral (LG) medial heads (MG) gastrocnemius as well soleus...

10.1113/jphysiol.1996.sp021214 article EN The Journal of Physiology 1996-02-15

To evaluate the accuracy of ultrasonography (US) in diagnosis carpal tunnel syndrome (CTS) patients with a bifid median nerve on basis cross-sectional area (CSA) measurements at level (CSAc), additional obtained more proximally (CSAp) pronator quadratus muscle.This HIPAA-compliant study was approved by local institutional review board; informed oral and written consent were obtained. Fifty-three wrists 49 consecutive CTS symptoms 28 27 healthy volunteers examined using US. Two independent US...

10.1148/radiol.11101644 article EN Radiology 2011-03-08

Abstract The phase III double-blind PROPEL study compared the novel two-component therapy cipaglucosidase alfa + miglustat (cipa mig) with alglucosidase placebo (alg pbo) in adults late-onset Pompe disease (LOPD). This ongoing open-label extension (OLE; NCT04138277) evaluates long-term safety and efficacy of cipa mig. Outcomes include 6-min walk distance (6MWD), forced vital capacity (FVC), creatine kinase (CK) hexose tetrasaccharide (Hex4) levels, patient-reported outcomes safety. Data are...

10.1007/s00415-024-12236-0 article EN cc-by Journal of Neurology 2024-02-28

Defects of mitochondrial polymerase γ (POLG) underlie neurological diseases ranging from myopathies to parkinsonism and infantile Alpers syndrome. The most severe manifestations have been associated with mutations the 'spacer' region POLG, function which has remained unstudied in humans. We identified a family, segregating three POLG amino acid variants, A467T, R627Q Q1236H. first two affect spacer third is polymorphism, allelic R627Q. Three grades disease severity appeared correlate...

10.1093/hmg/ddi196 article EN Human Molecular Genetics 2005-05-25
Coming Soon ...